Levemir
Product Images NDC 50090-6414

Product Visual Gallery

This gallery contains 59 technical images submitted to the FDA as part of the official labeling for Levemir (NDC 50090-6414). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levemir Chemical Structure.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 01)

Chemical structure diagram depicting the amino acid sequence and bonding of Levemir insulin analog. The structure includes labeled positions with disulfide bonds and a lipid modification attached to the lysine residue, characteristic of insulin detemir.*

FDA Label Image

Figure 4a (Aa947266 E27c 432b 8e04 C36168d24ddb 06)

An instructional illustration showing two hands holding a vial, with one hand removing or placing a cap on the vial. The image is labeled '4A' in the upper left corner.*

FDA Label Image

Figure 4b (Aa947266 E27c 432b 8e04 C36168d24ddb 07)

An instructional illustration showing a person holding a vial with one hand while using the other hand to manipulate the vial's top, likely preparing it for use or injection. The image is labeled with '4B' in the top left corner.*

FDA Label Image

Figure 6 (Aa947266 E27c 432b 8e04 C36168d24ddb 08)

An instructional illustration showing a pair of hands preparing a syringe by inserting the needle into the cap of a vial or pen and pushing down. The image includes a downward arrow indicating the motion of pushing down on the vial or pen cap.*

FDA Label Image

Figure 7 (Aa947266 E27c 432b 8e04 C36168d24ddb 09)

An instructional illustration showing a hand holding a bottle and drawing liquid into a syringe. It depicts the process of withdrawing medication from a vial using a syringe, typical in preparation for injection.*

FDA Label Image

Figure 8 (Aa947266 E27c 432b 8e04 C36168d24ddb 10)

An instructional diagram showing a pair of hands preparing a syringe with medication from a vial. One hand holds the vial upside down, while the other hand pulls the syringe plunger to draw liquid from the vial, indicated by a downward arrow. This image is likely part of medication preparation instructions for Levemir insulin.*

FDA Label Image

Figure 9 (Aa947266 E27c 432b 8e04 C36168d24ddb 11)

An instructional diagram illustrating a hand holding a vial of Levemir insulin and inserting a syringe or pen needle into the vial. The illustration shows the process of drawing medication from the vial by pressing downward on the plunger.*

FDA Label Image

Figure 10 (Aa947266 E27c 432b 8e04 C36168d24ddb 12)

An instructional illustration showing hands drawing liquid into a syringe from a vial. One hand holds the vial upside down, while the other hand operates the syringe, indicating preparation for injection.*

FDA Label Image

Figure 1 (Aa947266 E27c 432b 8e04 C36168d24ddb 13)

An instructional illustration showing a hand holding a syringe and needle angled downwards toward the skin of another person's thigh. The image indicates the proper angle and position for an injection, with an arrow pointing downward to guide insertion.*

FDA Label Image

Step 1 Fig B.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 28)

An instructional illustration labeled Figure B showing hands manipulating the green cap of a Levemir insulin pen, demonstrating the removal or adjustment of the pen cap prior to injection.*

FDA Label Image

Step 2 Fig C.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 29)

An instructional illustration showing a close-up of a hand holding a green and blue medical pen device, likely part of the Levemir insulin pen system by A-S Medication Solutions. The image focuses on the pen tip and the user's grip, labeled as Figure C.*

FDA Label Image

Figure D (Aa947266 E27c 432b 8e04 C36168d24ddb 30)

An instructional illustration showing how to use NovoFine and NovoTwist needles. The left panel demonstrates using NovoFine needles with an arrow indicating the detachment method, and the right panel shows NovoTwist needles with a similar directional arrow for removal.*

FDA Label Image

Figure E (Aa947266 E27c 432b 8e04 C36168d24ddb 31)

An instructional illustration showing two steps for using insulin injection devices labeled NovoFine, NovoFine Plus, and NovoTwist. The first step depicts attaching a needle at an angle to the pen, and the second step shows twisting a protective cap off the needle.*

FDA Label Image

Figure F (Aa947266 E27c 432b 8e04 C36168d24ddb 32)

An instructional illustration showing two steps for using a NovoFine Plus needle with a NovoTwist device. The left panel depicts inserting the NovoFine Plus needle by pushing, indicated by a blue arrow. The right panel shows twisting the needle onto the device, also indicated by a blue arrow.*

FDA Label Image

Figure G (Aa947266 E27c 432b 8e04 C36168d24ddb 33)

An instructional illustration showing how to connect a syringe to a vial and how to use a NovoTwist connection system for drawing medication. The left side depicts a traditional syringe-vial connection labeled 'NovoFine, NovoFine Plus,' and the right side shows a NovoTwist connection method labeled 'NovoTwist.' Arrows indicate the steps for attachment and medication withdrawal.*

FDA Label Image

Step 7 Fig H.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 34)

An instructional illustration showing how to set a dose of 2 units on an insulin pen injector. The image depicts hands adjusting the dose selector with a close-up inset highlighting the 2-unit dose chosen.*

FDA Label Image

Step 8 Fig I.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 35)

Illustration showing a close-up of a hand holding a pen-like device, identified as Levemir insulin pen, with motion lines indicating shaking or movement of the pen. The image highlights preparing the insulin pen for use.*

FDA Label Image

Step 9 Fig J.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 36)

An instructional illustration showing a hand holding a Levemir insulin pen. The image highlights the top of the pen with a focus on the needle area, accompanied by an arrow pointing upward, likely indicating how to remove the needle cap or prepare the pen for injection.*

FDA Label Image

Step 10 Fig K.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 37)

An instructional illustration showing how to select insulin dosage units on a Levemir pen device. Two examples indicate selecting 5 units and 24 units, with a close-up view of the dose window displaying numeric unit selections on the dial.*

FDA Label Image

Step 10 Fig L (Aa947266 E27c 432b 8e04 C36168d24ddb 38)

An illustration showing a close-up view of a pen-type insulin injector with an estimated 200 units of insulin remaining. The pen features a transparent window with unit markings and a plunger partially depressed inside the cartridge. The text on the left side indicates the approximate units left inside the device. This image is likely part of usage instructions for Levemir insulin pen by A-S Medication Solutions.*

FDA Label Image

Step 11 Fig M (Aa947266 E27c 432b 8e04 C36168d24ddb 39)

Illustration showing recommended injection sites on a human body for a medication. Highlighted areas include the upper arms, abdomen, front and outer sides of the thighs, and the upper buttocks/lower back region. Views include both front and back of the body.*

FDA Label Image

Step 12 Fig N.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 40)

An instructional illustration showing a hand holding the Levemir insulin pen with the cap removed, positioned over the skin for injection. A downward arrow indicates the action of pressing the pen against the skin to administer the dose. The figure is labeled as Figure N beneath the image.*

FDA Label Image

Step 13 Fig O.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 41)

An instructional illustration showing a hand gripping a pen-like injector device with an arrow pointing downward, indicating the injection motion. A dose dial on the injector displays the number 20, representing dosage adjustment or selection.*

FDA Label Image

Step 13 Fig P.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 42)

An instructional illustration showing a hand holding a syringe, with a speech bubble instructing to count slowly from 1 to 6. The image likely depicts a step of preparing or using Levemir insulin, emphasizing slow counting during the process.*

FDA Label Image

Step 14 Fig Q.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 43)

An instructional illustration showing a syringe with liquid, positioned vertically with an upward arrow indicating removal or extraction motion. The figure is labeled as 'Figure Q' and is likely part of a medication administration or preparation guide.*

FDA Label Image

Step 15 Fig S.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 45)

An instructional diagram showing the insertion of a needle into a cap or connector, indicated by arrows directing the needle towards the cap. The image appears to guide users on assembling parts, likely related to medication administration with a syringe or pen device.*

FDA Label Image

Step 16 Fig T.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 46)

Illustration showing a close-up of hands twisting or removing a green band or cap from a pen-like device, with an arrow indicating the direction of the twist or removal. The image is likely an instructional figure related to the handling of the Levemir insulin pen by A-S Medication Solutions.*

FDA Label Image

Flextouch Qr Code (Aa947266 E27c 432b 8e04 C36168d24ddb 50)

FDA Label Image

Important Message (Image 01)

The image shows a box of Levemir insulin product by A-S Medication Solutions. The packaging is white with accents of purple and pink. It includes the brand name Levemir prominently, with details likely indicating dosage form and strength, along with use instructions or regulatory information in smaller text.*

FDA Label Image

Important (Image 02)

Levemir insulin product carton labeled with A-S Medication Solutions as the labeler. The packaging includes dosing instructions and barcode details, with small visible text and logos indicating it is a pharmaceutical insulin product.*

FDA Label Image

Needle Components. (Image 03)

Illustrations showing components of three different needle types named NovoFine, NovoFine Plus, and NovoTwist. Each set displays an outer needle cap, inner needle cap, needle, and a paper tab aligned horizontally.*

FDA Label Image

Figure A Flextouch Pen Components. (Image 04)

An instructional diagram showing the components of a Levemir FlexTouch insulin pen. Labeled parts include the pen cap, insulin scale, insulin window, dose counter, dose selector, dose pointer, and dose button.*

FDA Label Image

Step 15 Figure R (Image 05)

An instructional diagram showing two steps for using an injection pen device, likely for Levemir insulin. The left panel illustrates a twisting or locking motion, while the right panel shows a forward pressing action on the injection pen, indicating proper handling or dose administration technique.*

FDA Label Image

Figure 2: Graph Of Glucose Lowering Effect In Patients With Type 1 Diabetes (Image 06)

A pharmacodynamic graph for Levemir showing glucose infusion rate (mg/kg/min) versus time since insulin injection (hours), with curves for 0.2 Units/kg and 0.4 Units/kg doses. The chart includes a table of pharmacodynamic parameters, AUC and GIRmax, for each dose.*

FDA Label Image

Figure 3: Graph Of Glucose Lowering Effect In Patients With Type 2 Diabetes (Image 07)

A pharmacodynamic parameter chart for Levemir showing glucose infusion rate (mg/kg/min) over time (hours) since insulin injection for two dosages: 0.6 Units/kg (solid line) and 1.2 Units/kg (dashed line). The accompanying table summarizes AUC_GIR and GIR_max values for each dosage.*

FDA Label Image

Important Message (Image 08)

Levemir insulin injection pen label from A-S Medication Solutions. The label includes dosage details and other regulatory information prominently displayed on a white background with green and blue design elements. The product NDC code 50090-6414 is visible on the label.*

FDA Label Image

Important Message (Image 09)

Levemir box labeled as an injectable product containing insulin detemir. The packaging is primarily white with blue and orange accents. The label shows the brand name Levemir prominently and includes the A-S Medication Solutions labeler name. The box also displays a red and white shield logo.*

FDA Label Image

Important (Image 10)

Levemir vial packaging label by A-S Medication Solutions. The label includes the product name Levemir, its strength in U-100 per mL, and the vial dosage form. The label also shows the product has a net volume of 10 mL. The label has additional product and regulatory information in small print.*

FDA Label Image

Important (Image 11)

Levemir insulin injection cartridge label showing a 10 mL cartridge for use with the FlexTouch pen. The label includes the proprietary name Levemir, strength details, and labeler A-S Medication Solutions. It displays dosage form, volume, lot number, and storage instructions.*

FDA Label Image

Important Message (Image 12)

Levemir 100 Units/mL Insulin Detemir Injection vial, 10 mL, by A-S Medication Solutions. The brown glass vial features a label displaying the product name, strength, and volume with dosage instructions and regulatory text in black and blue on a white background.*

FDA Label Image

Image Of Components For Levemir Flexpen And Needles. (Image 13)

Illustration showing the parts of a LEVEMIR FlexPen injector, including pen cap, rubber stopper, cartridge, cartridge scale, dose pointer selector, and push-button. Additionally, it depicts components of NovoFine and NovoFine Plus needles, such as big outer needle caps, inner needle caps, needles, and protective tabs.*

FDA Label Image

Fp A (Image 14)

Illustration showing a close-up of hands holding an insulin pen. One hand appears to be adjusting or preparing the pen by moving a dial or cap, indicated by an arrow pointing away from the pen. The image likely demonstrates a step in the usage instructions for the Levemir insulin pen.*

FDA Label Image

Fp B (Image 15)

Illustration depicting a hand removing a cap from a green Levemir injection pen, shown by an upward arrow indicating the cap is being pulled off the pen tip.*

FDA Label Image

Fp C (Image 16)

Illustration showing a step for preparing an injection with a syringe and a vial or cartridge. A hand is positioned to attach or detach a needle hub from a green syringe barrel, indicated by a directional arrow.*

FDA Label Image

Fp D (Image 17)

An instructional illustration demonstrating how to remove a cap from a pen injector, specifically for Levemir by A-S Medication Solutions. The image shows a hand pulling the cap straight off the device with a directional arrow indicating the motion.*

FDA Label Image

Fp E (Image 18)

An instructional illustration showing how to set the dose on a Levemir injection pen. The image depicts hands turning the dose selector dial on the pen, with a close-up inset displaying a dose of 2 units selected. The pen is blue and labeled with metric numbers for dose adjustment.*

FDA Label Image

Fp F (Image 19)

An instructional illustration showing a finger tapping or flicking the top of a green syringe. The image emphasizes a step likely involved in preparing or priming the syringe before use.*

FDA Label Image

Fp G (Image 20)

An instructional illustration showing a hand holding a Levemir insulin pen with an arrow pointing upward, indicating the removal of the pen cap. A smaller inset shows the pen needle and its protective cover, demonstrating how to detach the needle cover prior to injection.*

FDA Label Image

Fp H (Image 21)

An instructional illustration showing how to set the dose on a Levemir insulin pen. It depicts fingers turning the dosage selector with close-ups of the dose window displaying 5 units, 4 to 6 units, and 24 units selected.*

FDA Label Image

Fp I (Image 22)

Instructional illustration showing a hand pressing down on the cap of a Levemir insulin pen to prepare the injection. The pen's dial and injection mechanism are partially visible, indicating dose setting and delivery.*

FDA Label Image

Fp J (Image 23)

An illustration showing a close-up of a syringe needle penetrating or touching the skin, demonstrating an injection technique or site. The syringe barrel and needle are partially visible, with the needle oriented downward toward the skin surface.*

FDA Label Image

Fp K (Image 24)

An instructional illustration showing a close-up of a person's hand holding the green cap of a Levemir pen, with arrows indicating the direction to remove the cap. This image visually guides how to take off the needle cap from the insulin injection pen.*

FDA Label Image

Important Message (Image 25)

Levemir packaging label from A-S Medication Solutions, showing a vial of Levemir insulin injection solution. The image displays a single vial with a purple cap next to its white carton box. The vial and box both feature the Levemir name prominently.*

FDA Label Image

Important Message (Image 26)

Levemir packaging label from A-S Medication Solutions. The label includes the brand name Levemir prominently displayed with stylized orange and black design elements. It is a rectangular label with registration marks on the sides, intended for product identification and packaging.*

FDA Label Image

Important Message (Image 27)

Levemir is shown on a white vial label with blue and gray accents. The label includes the product name Levemir prominently, but does not clearly display strength or dosage form on the visible portion. The labeler is not explicitly visible on the vial label portion shown. The vial likely contains an insulin product, inferred by the brand name visible.*

FDA Label Image

Important Message (Image 28)

Levemir is displayed as a clear plastic vial with a blue cap and a label wrapped around it. The label includes text and numeric markings, likely for dose measurement, and the vial contains clear liquid. The product is labeled by A-S Medication Solutions with NDC 50090-6414.*

FDA Label Image

Important Message (Image 29)

Levemir packaging showing a vial label for injection. The label includes the proprietary name Levemir, and indicates it is a product of A-S Medication Solutions. The vial is transparent with brown and white colors on the label. The product NDC is 50090-6414.*

FDA Label Image

Important Message (Image 30)

Levemir 100 units per mL insulin solution in a 10 mL vial. The label shows the proprietary name Levemir and indicates it is a solution for subcutaneous injection. The labeler is A-S Medication Solutions. The product NDC 50090-6414 is visible on the label.*

FDA Label Image

Label Image (Lbl500906414)

Levemir FlexPen (Insulin Detemir) Injection 100 units/mL (U-100) in a 5 x 3 mL prefilled pen carton label from A-S Medication Solutions. The label includes storage instructions to refrigerate unopened pens at 36 to 46 degrees Fahrenheit and protect from light, with a warning not to freeze. The product NDC is 50090-6414-0.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.